Quotidien Corporate & Crypto Finance - Daily News


              



Evolva: Oliver Walker nommé CFO en remplacement de Jakob Dynnes Hansen


Evolva annonce mardi la nomination de Oliver Walker au poste de directeur financier (CFO) à compter du 1er décembre, en remplacement de Jakob Dynnes Hansen. Le titulaire actuel du poste conservera une occupation à temps partiel afin d'assurer une transition fluide et doit prendre congé de l'entreprise au deuxième trimestre de l'année prochaine, précise le communiqué du spécialiste des édulcorants et autres compléments alimentaires.



M. Walker a auparavant exercé des fonctions similaires pour notamment le singapourien Sivantos, ou pour les représentations helvétiques de Nobel Biocare, Sonova ainsi que Stratec.

Communiqué original :

Strong track record as CFO of Nobel Biocare, Sonova and Stratec

Evolva (SIX: EVE) Evolva announces the appointment of Oliver Walker as its Chief Financial Officer (CFO) effective 1st December 2016.

Oliver Walker is a finance executive with more than 20 years of experience in international companies, both listed and privately-held, and was active in high growth industries and mature industries alike. Amongst other senior positions he was previously CFO of several leading Life Sciences companies, including Sivantos (Singapore), Nobel Biocare, Sonova and Stratec (all Switzerland). His experience covers all aspects of finance including M&A, capital market transactions, treasury, reporting and fundraising. Oliver has an MSc in Business Administration & Economics at the University of Berne. He is a Swiss national, born in 1969.

Neil Goldsmith, CEO of Evolva said, “I look forward to working with Oliver to take Evolva to the next stage. His experience as an entrepreneurial CFO in diverse life science, high tech and manufacturing companies will be very useful to Evolva. Oliver has a strong track record in driving operations and managing growth and brings an extensive network, both in the Swiss financial sector and abroad.”

Oliver said, “I am excited to join Evolva and make a contribution to bringing this dynamic and innovative company to strong and sustainable profitability. Jakob has given the company a solid financial foundation and I am confident my experience will be valuable in building on this basis.”

The current CFO, Jakob Dynnes Hansen, will remain at Evolva on a part-time basis to secure a smooth transition and is expected to depart in the second quarter of 2017. Jakob will return to his native Denmark, taking up a part time CFO position at Acesion Pharma, a young pharma-biotech company.

evolva.com

Les médias du groupe Finyear

Lisez gratuitement :

FINYEAR

Le quotidien Finyear :
- Finyear Quotidien

Sa newsletter quotidienne :
- Finyear Newsletter
Recevez chaque matin par mail la newsletter Finyear, une sélection quotidienne des meilleures infos et expertises en Finance innovation & Digital transformation.

Ses 5 lettres mensuelles digitales :
- Le Directeur Financier
- Le Trésorier
- Le Credit Manager
- The Chief FinTech Officer
- The Chief Digital Officer

Finyear magazine trimestriel digital :
- Finyear Magazine

Un seul formulaire d'abonnement pour choisir de recevoir un ou plusieurs médias Finyear

BLOCKCHAIN DAILY NEWS

Le quotidien Blockchain Daily News :
- Blockchain Daily News

Sa newsletter quotidienne :
- Blockchain Daily News Newsletter
Recevez chaque matin par mail la newsletter Blockchain daily News, une sélection quotidienne des meilleures infos et expertises en Blockchain révolution.

Sa lettre mensuelle digitale :
- The Chief Blockchain Officer

Lundi 5 Décembre 2016
Notez


Nouveau commentaire :
Twitter

Your email address will not be published. Required fields are marked *
Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Finyear: latest news, derniers articles

Free Daily Newsletter / Newsletter quotidienne gratuite


Cryptocurrencies




Finyear - Daily News